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Objective. To determine any changes in tuberculosis epidemiology in the last 15 years in Benin, seasonal variations, and forecasted
numbers of tuberculosis cases in the next five years. Materials and Methods. Retrospective cohort and time series study of all
tuberculosis cases notified between 2000 and 2014. The “R” software version 3.2.1 (Institute for Statistics and Mathematics Vienna
Austria) and the Box-Jenkins 1976 modeling approach were used for time series analysis. Results. Of 246943 presumptive cases,
54303 (22%) were diagnosed with tuberculosis. Annual notified case numbers increased, with the highest reported in 2011. New
pulmonary bacteriologically confirmed tuberculosis (NPBCT) represented 78% ± SD 2%. Retreatment cases decreased from 10%
to 6% and new pulmonary clinically diagnosed cases increased from 2% to 8%. NPBCT notification rates decreased in males from
2012, in young people aged 15–34 years and in Borgou-Alibori region.There was a seasonal pattern in tuberculosis cases. Over 90%
of NPBCT were HIV-tested with a stable HIV prevalence of 13%. The ARIMA best fit model predicted a decrease in tuberculosis
cases finding in the next five years. Conclusion. Tuberculosis case notifications are predicted to decrease in the next five years if
current passive case finding is used. Additional strategies are needed in the country.
1. Introduction
Despite the discovery of the causative agent more than one
century ago, a vaccine, highly effective medications, and re-
cent improvements in biological molecular field and genetic
engineering, tuberculosis (TB) remains a major public health
concern in the world. In 2014, globally, there were estimated
9.6million incident cases, of which 1.5millionwere estimated
to have died. The burden of the disease is particularly
immense in Africa from where the case rate was reported to
be 281 per 100000 people [1].
The year 2016 is an important turn for the TB world, with
the World Health Organization (WHO) launching the “End
TB Strategy” with ambitious new targets of reducing by 2035
the incidence and the mortality of the disease by 90% and
95%, respectively, comparedwith 2015 [2]. Success in this new
strategy requires additional and relevant actions/strategies
at both international and national levels. In countries, such
actions/strategies cannot be properly planned without a clear
understanding of the past and current local epidemiology of
the disease.
Benin is a small country in West Africa with an area
of 114763 km2 for a population of 10008749 inhabitants in
2013 [3]. With activities just restricted to a mass BCG
vaccination before 1966, TB care activities in the country
significantly improved from 1972 with the establishment of
the National TB Programme (NTP). An epidemiological
review of TB patients diagnosed in the country between
1995 and 2007 showed an average of notified new pulmonary
bacteriologically confirmed TB (NPBCT) cases of 35 per
100000 inhabitants, with a slight increase of 1% per annum.
Large variations were observed in notifications of TB cases
between the north and the south of the country, in line
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with population densities. The male-female sex ratio was 1.8
and no change in the age structure was reported. Human
Immunodeficiency Virus (HIV) prevalence of the 97% of TB
patients that were tested was 14% [4].
As implementation of the “End TB Strategy” commences,
it is important to better understand the new challenges and to
determine whether the local TB epidemiology has changed
over time. There is also no information available within the
national tuberculosis control programme on the relationship
between seasons and TB case finding. This information may
be useful in forecasting the number of TB cases expected in
Benin in the coming years.
The current study was therefore undertaken (i) to assess
whether there were any changes in the local TB epidemiology
the last fifteen years and (ii) to determine the forecasted
number of TB cases in the next five years. Specific objectives
were to determine, between 2000 and 2014, in Benin (i) the
trend of presumptive and notified TB cases; (ii) the trend of
the different types and categories of TB cases; (iii) any changes
in baseline characteristics andHIV-status of notifiedNPBCT;
(iv) any seasonality in TB case finding in the country; and (v)
the forecasted number of TB cases that might be diagnosed
within the programme in the next five years.
2. Materials and Methods
2.1. Study Design. This was a retrospective cohort and time
series study of notified TB patients, using routinely collected
data.
2.2. General Setting and Study Sites
2.2.1. Country. Benin shares borders with Burkina Faso and
Niger in the north, Togo in the west, Nigeria in the east,
and the Atlantic Ocean in the south. The country is low-
income with a Gross National Income per capita estimated
at US$ 810 in 2014. The under-five and maternal mortality
rates were 85 per 1000 live births and 340 per 100 000 live
births, respectively, in 2013 [5]. HIV prevalence among adults
aged between 15 and 49 years was 1.1% in 2012 [6]. For
decades, BCG vaccination has been implemented in public
and also some appointed health facilities in the country. BCG
vaccination is recommended within the first two weeks after
birth. In 2014, the coverage ratewas 96% [7]. BCGvaccination
is free of charge.
Administratively, the country is divided into six func-
tional departments: Atacora-Donga and Borgou-Alibori in
the north, Zou-Collines in the centre, and Mono-Couffo,
Oueme-Plateau, and Atlantique-Littoral in the south. Cot-
onou the economic capital is located in Atlantique-Littoral.
The density of the population gradually increases from the
north to the south, with the highest population density
reported from Cotonou. Overall in Benin, the climate is hot
and humid.There were two rainy seasons (a principal season
from April to July and a shorter season from September to
November) and two dry seasons (a principal season from
December to April and a shorter season from July to Septem-
ber).
2.2.2. The National Tuberculosis Control Programme (NTP)
Organization and Function. The NTP is under the Ministry
of Health and has a pyramidal organizational structure with
three (central, intermediate, and peripheral) levels, based on
the general health systemmodel. Diagnosis, registration, and
treatment are decentralized to 57 BMUs (48 public and 9 con-
fessional health facilities) at peripheral levels. Attempts had
been made previously to include private clinics but with no
success, because the private sector is benefits-oriented, con-
trary to the programme’s objective of making all TB-related
activities free of charge (consultations and/or examination
charges for diagnosis, treatment, and follow-up). However,
these private clinics are not completely excluded from TB
activities. Their workers are regularly trained to identify and
refer to the closest BMUpatients with presumptive symptoms
of TB. This system functions well. There is supervision of all
the 57 BMUs organized by the central and intermediate levels
of the TB Programme on a quarterly basis.
Diagnosis, Treatment, and Case Notification. Diagnosis and
treatment are provided in line with the WHO and The
Union recommendations [8, 9]. Overall, a passive screening
strategy is routinely performed, although in 2011 there was
some experimentation with a semiactive case finding strategy
named “TB Reach” funded by the WHO. The laboratory
network is made up of 57 laboratories in BMUs with 10
additional centres for microscopic diagnosis. In these labora-
tories, specimens from all presumptive TB cases (regardless
of their public, confessional, or private sector origin) are
analysed mainly using Ziehl-Neelsen staining and/or fluo-
rescence auramine microscopy. Fluorescent microscopy was
first introduced into the largest BMU of the country twenty
years ago. Since then, this technology has been scaled up to six
regional laboratories in 2010 and to 10 other laboratories with
the highest workloads in 2014. With the new Global Fund
against AIDS, Tuberculosis and Malaria (GFATM) grant, the
rest of the laboratories in the network will be equipped with
fluorescent microscopy by 2017.
In addition to microscopy, phenotypic culture on solid
medium (Lo¨wenstein-Jensen) followed by identification
and drug susceptibility testing is routinely carried out at
the mycobacteria national laboratory. Since 2012, Xpert
MTB/RIF (Cepheid Inc., Sunnyvale, CA, USA) has also been
available in this laboratory. This technology is not part of
the routine diagnosis strategy of all TB cases but is mainly
used for (1) detecting patients earlier with resistance to
rifampicin, almost synonymous with multidrug-resistant TB
and (2) diagnosing HIV-infected patients with presumptive
symptoms of TB. On the first targeted population, in Benin,
rifampicin resistant patients are mostly found among retreat-
ment TB cases. Thus, all previously treated patients positive
on smear microscopy are tested. In 2016, Xpert MTB/RIF
(Cepheid Inc., Sunnyvale, CA, USA) was scaled up in the six
regional laboratories. In the short term, decentralization of
these machines at peripheral levels is not possible because
of various technological and other constraints (e.g., cost,
environmental temperatures, shelf-life of cartridges, electric-
ity supplies in a country where electricity is neither stable
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nor permanent, and the need for annual calibration of the
machine) [10].
Once the diagnosis is confirmed, patients are registered
in the “TB registers” which are only available in the 57 BMUs.
Those, who reside far from the place of diagnosis, are sent to
the BMU closest to their domicile and registered in that new
BMU.
Treatment is then started and is in line withWHO recom-
mendations. All consultations, bacteriological examinations,
treatment, and follow-up are provided free of charge. Anti-
TB drugs are not available in private pharmacies but only in
BMUs. This presents an advantage for TB notification com-
pleteness since patients have to be sent to one of the 57 BMUs
and be registered before starting treatment. For all pulmonary
TB bacteriologically confirmed cases through microscopy,
treatment is directly observed during the intensive phase.
Within the first two weeks after the end of each quarter, a
report on TB cases diagnosed during these three months and
also outcomes of the cohort of patients put on treatment one
year earlier is made by the nurse under the responsibility of
the medical doctor. A visit is then made by the supervision
team; and the report is checked (and corrected if necessary)
before being brought back to the coordinator for national
statistics. To date, the notification system is paper based, but
the programme is about to move to an electronic notification
system (District Health Information System 2 developed by
the University of Oslow).
TB/HIV Coinfection Management. Since 2006, all TB cases
in the country have been systematically offered HIV testing.
Thosewho are found coinfectedwithTB andHIV receive cot-
rimoxazole (CTX) for opportunistic infections prevention.
Since 2010, antiretroviral therapy (ART) has been initiated for
all coinfected TB/HIV patients, regardless of their CD4 cell
counts [11].
Financing. TB activities are funded by the government.
However, similar to many other developing countries, an
important component of the funding is provided by the
International Institutions, especially the Global Fund against
AIDS, Tuberculosis and Malaria (GFATM). In 2014, 48% of
the national programme needs were internationally funded
[12].
2.3. Study Population. All TB patients registered in the NTP
between 2000 and 2014 were included in the study.
2.4. Data Variables, Data Sources, Data Validation, and
Definitions. Aggregate data were collected for this study
and included number of presumptive TB cases, number
of notified TB cases (all types), number of NPBCT cases
(patients never treated or treated with anti-TB drugs for
less than 1 month, whose TB diagnosis was bacteriologically
confirmed on sputa by smear microscopy, culture, or WHO-
approved rapid diagnostics such as Xpert MTB/RIF), new
pulmonary clinically diagnosed TB (patients with pulmonary
disease never treated or treated with anti-TB drugs for less
than 1 month who did not fulfil the criteria for bacterio-
logical confirmation but were diagnosed with active TB by
a clinician who decided to give the patient a full course
of TB treatment), new extrapulmonary TB (patients never
treated or treated with anti-TB drugs for less than 1 month
with a bacteriological or a clinical diagnosis of TB involving
anatomical sites other than the lungs), retreatment TB (or
previously treated patients who received 1 month or more of
TB treatment in the past. They included relapse, treatment
after failure, and treatment after loss to follow-up cases)
[13], demographical characteristics of NPBCT cases (sex, age
group, and department), andHIV-status of NPBCT (positive,
negative, and unknown). These data were collected into
paper based quarterly reports and validated during quarterly
supervisions. They were then entered into a Microsoft Excel
file.
2.5. Analysis and Statistics. Baseline characteristics, types of
TB, and HIV-status were described using frequencies and
percentages.The notified NPBCT rates in males, females, age
groups, and departments were calculated from the general
population. For the time series analysis, the number of TB
cases notified half-yearly between 2000 and 2014 was derived.
The “R” software version 3.2.1 (Institute for Statistics and
Mathematics, Vienna, Austria) and the Box-Jenkins (1976)
modeling approach were used to analyse the time series and
to determine the best suitable model for the time series data.
The Ljung-Box-Pierce test was performed to check whether
the model was correctly specified. Levels of significance were
set at 5%.
2.6. Ethical Considerations. Permission for the study was
obtained from the NTP management staff. Approval from
the local Ethics Committee “Comite´ National d’Ethique
pour la Recherche en Sante´” (http://www.ethique-sante.org/
index.htm) was not required because of the retrospective
nature of this study according to the country’s recommenda-
tion.Approvalwas also not required from the EthicsAdvisory
Board of the International Union against Tuberculosis and
Lung Disease (The Union) because of the use of aggregate
not individual data. The study used already collected data.
Therefore, written informed consent given by participants
was not possible to obtain. Since aggregate data were used for
the study, there was no way to recognize participants.
3. Results
3.1. Cases Detection and Types of TB. Between 2000 and
2014, of the 246943 TB presumptive patients, 54303 (22%)
were diagnosed with TB.The numbers/trends of presumptive
and diagnosed TB patients seen, respectively, over these
fifteen years are shown in Figure 1. There was a progressive
increase in the number of patients being investigated for
TB. In the same manner, the number of diagnosed TB
cases also increased. The maximum number of presumptive
and diagnosed TB cases was reported in 2011 and this was
followed by a decrease the year after. Figure 2 shows the dif-
ferent types of TB diagnosed over the study period. NPBCT
through microscopy represented the large majority of TB
cases diagnosed (average = 78% [±SD 2%]). Retreatment TB
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Figure 1: Trend of presumptive and notified tuberculosis cases in
Benin, 2000–2014.
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Figure 2: Different types of tuberculosis diagnosed in Benin, 2000–
2014.
patients declined from at least 10% in the first five years to
about 6% in the last few years while new pulmonary clinically
diagnosed TB cases slightly increased from 2% to 8%.
3.2. Baseline Characteristics and HIV-Status Variation. Base-
line characteristics and HIV-status of patients are shown
in Figures 3(a), 3(b), 3(c), and 3(d). Among NPBCT, the
notification rate was 1.5 times higher in males compared to
females. However, from 2012 onwards there was a decrease in
male case numbers (Figure 3(a)). TB case notification rates
Table 1: Estimation of the coefficient of the best fit model for the TB
case finding time series.
MA1 AR1 Intercept
0.6037 0.865 1759.7924
Standard error 0.2232 0.092 163.3689
Best fit model ARIMA (0, 0, 1) (1, 0, 0) with constant
Convergence
criteria
Log likelihood = −182.67; AIC =
373.33; BIC = 378.94
Note: MA: moving average; AR: autoregressive.
decreased among young people aged from 15 to 34 years
compared with older people (Figure 3(b)). The Atlantique-
Littoral region continuously reported the highest rate of
TB during the last ten years while a decrease in cases was
noticed in Borgou-Alibori (Figure 3(c)). The proportion of
TB patients tested for HIV was high (>90%) while the
prevalence of HIV positive status amongNPBCT cases tested
was quite constant each year at 13% (Figure 3(d)).
3.3. Seasonality of TB Case Detection and Forecasted Numbers
over the Next Five Years. The time series analysis of TB
cases diagnosed between 2000 and 2014 in Benin is shown
in Figures 4(a), 4(b), and 4(c). The raw graph of all cases
diagnosed each semester showed an overall gradual increase
of these cases over the study period, with several peaks
suggesting a cyclical seasonal pattern in TB case finding
(Figure 4(a)). This assumed that the TB case finding time
series was composed of a trend (gradual increase over time),
seasonal variations (several peaks at regular intervals), and
a residual component. After a profiles method, the additive
model was the most appropriate to decompose this time
series.Thedecomposition into trend, seasonality and residual
components is shown in Figure 4(b). Trend analysis showed
upward-sloping but not linear curve. The seasonality curve
described an alternative and regular fluctuation in the inter-
val (52.009; −52.009) over the study period. Overall, in each
year, except 2004, 2005, and 2008, the number of TB cases
notified for the first semester was higher than that reported
for the second semester. The residual component was on
average generally constant over the period. The Dickey-
Fuller test confirmed that this time series was effectively
stationary (Dickey-Fuller = −5.781, Lag order = 3, and 𝑃
value = 0.01). The Autocorrelation Function (ACF) and
the Partial Autocorrelation Function (PACF) suggested an
Autoregressive IntegratedMoving Average (ARIMA) (2, 0, 3)
model (Figure 4(c)).The coefficients of the autoregressive and
moving average parts of the best fit model were determined
and are presented in Table 1. The best fit model for this time
series was therefore ARIMA (0, 0, 1)(1, 0, 0) with a constant.
This model was validated using the Ljung-Box-Pierce test
(chi-squared = 11.939, df = 1, 𝑃 < 0.001), confirming thereby
that the residual components in this time series were white
noises (i.e., independent and identically distributed).
Finally, the forecasted number of TB cases per semester
between 2015 and 2019 was calculated and is presented in
Table 2. The numbers of TB cases are predicted to decrease
during these next five years (see Figure 5).
Tuberculosis Research and Treatment 5
(Year)
Ca
se
s p
er
 1
00
00
0
2000 2002 2004 2006 2008 2010 2012 2014
20
25
30
35
40
45
Male
Total
Female
(a)
2000 2002 2004 2006 2008 2010 2012 2014 2000 2002 2004 2006 2008 2010 2012 2014
26
28
30
32
34
36
38
2000 2002 2004 2006 2008 2010 2012 2014
65
70
75
80
85
2000 2002 2004 2006 2008 2010 2012 2014
2000 2002 2004 2006 2008 2010 2012 2014
60
65
70
75
2000 2002 2004 2006 2008 2010 2012 2014
50
55
60
65
80
60
40
20
0
78
74
70
66
0–14 years
50
45
55
60
65 years and over
2000 2002 2004 2006 2008 2010 2012 2014
(Year)
45–54 years 55–64 years
25–34 years 35–44 years
Ca
se
s p
er
 1
00
00
0
Ca
se
s p
er
 1
00
00
0
Ca
se
s p
er
 1
00
00
0
Ca
se
s p
er
 1
00
00
0
Ca
se
s p
er
 1
00
00
0
Ca
se
s p
er
 1
00
00
0
Ca
se
s p
er
 1
00
00
0
15–24 years
(b)
Figure 3: Continued.
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Figure 3: Trend of baseline characteristics and HIV positive status of tuberculosis patients between 2000 and 2014, Benin. (a) Sex in NPBCT;
(b) age group in NPBCT; (c) regions of diagnosis for all TB; (d) HIV prevalence in NPBCT.
Table 2: Forecasted number of tuberculosis patients predicted to be diagnosed between 2015 and 2018 in Benin.
2015 2016 2017 2018 2019
S1 S2 S1 S2 S1 S2 S1 S2 S1 S2
Prevision 1989 1917 1958 1896 1931 1877 1908 1861 1888 1848
[IC 95%] [1788–2189]
[1683–
2152] [1666–2250] [1586–2206] [1587–2275] [1522–2234] [1529–2287] [1475–2249] [1485–2291] [1439–2257]
Note: S: semester; IC 95%: 95% forecasting interval.
4. Discussion
This study aimed to describe in Benin, at the start of the
new Global End TB Strategy, changes that occurred in the
epidemiology of TB patients during the previous fifteen
years and the predicted trend in TB case finding in the
following five years. We found that between 2000 and 2014,
the number of presumptive and notified TB cases slightly
increased. In contrast to new pulmonary clinically diagnosed
TB cases that increased during this time period, the propor-
tion of retreatment TB cases decreased. Patients who were
found NPBCT positive on microscopy regularly comprised
at least three-quarters of all notified TB cases. With respect
to demographic characteristics, the burden of the disease
was consistently higher among males compared to females.
However, from 2012 onwards, there was a striking decrease
in males being notified with TB. The burden of disease also
decreased among younger adults aged less than 34 years, who
also constituted a large proportion of the TB population.The
Atlantique-Littoral region continued to drive the epidemic
in the country, while there was a drop in notified cases in
Borgou-Alibori.
HIV testing in TB patients was excellent, with each year
over 90% of patients tested. Of those who were tested, one in
seven was annually found to be coinfected, with no change
observed in this proportion over these fifteen years. The
findings showed a seasonal variation in TB case finding and
notification, with a higher number of TB cases reported at the
end of the first semester of each year. Finally, the forecasted
number of TB cases to be diagnosed and notified in the next
five years was predicted to decrease if only the current passive
screening strategy in the country is applied.
The strengths of this study were that it involved all TB
patients in the country who were notified to the NTP and
therefore there was no need for any sampling framework.
Data used were also previously validated during regular
quarterly supervisions which contributed to minimizing
errors.The study followed the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) guidelines
[14]. Limitations were related to the retrospective nature of
the study.
One of the major concerns that came from our findings
was the decrease of TB cases in men and young adults
and also the decline in the forecasted numbers that will
be notified in the next five years. Taking into account the
most important achievement within the programme, that is,
a treatment success rate of 90% or more among NPBCT in
these last six years [12], it is possible that the programme has
significantly cut down transmission of infection from index
smear-positive cases leading to a reduction in the burden of
TB in the country. However, this belief should be interpreted
with caution for several reasons.
First, the programme routinely uses a passive strategy
for TB screening. The decrease reported in the study is
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Figure 4: Time series analysis of all tuberculosis cases diagnosed, 2000–2014, Benin. (a) Tuberculosis cases diagnosed per semester;
(b) decomposition of tuberculosis cases diagnosed with an additive model; (c) Autocorrelation and Partial Autocorrelation Functions of
tuberculosis time series.
therefore related to TB cases that reached health facilities.
Unfortunately, the utilization of the national health services
remains low, estimated at 51.4% in 2013 [15]. In other words,
TB cases that occurred in those not accessing TB services
will not be diagnosed and notified. The increase in notified
TB cases reported in the year of the “TB Reach” experience
followed by a decrease after this adds weight to this theory.
Advantages of a semiactive case finding strategy have also
been reported elsewhere [16, 17]. The high cost-efficacy
of a semiactive case finding strategy does not allow it to
be routinely performed in a resource-constrained setting,
although this should always be considered. In 2015 and with
the positive impact of the “TB Reach” experience on TB case
finding, the GFATM authorized the implementation of other
active case finding strategies in the country. An additional
measure to be taken into account for reaching those who do
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not use health facilities could be to strengthen sensitization
especially among traditional practitioners who, most of time,
are at the front line for providing care.
Second, it is possible that patients of some vulnerable
groups such as HIV-infected patients, those with diabetes
mellitus, and pregnant womenwere not diagnosed, since they
were not systematically screened by practitioners for TB at
each visit, unless they complained themselves of presumptive
TB symptoms. Actions to address this shortfall and also
implementation of some semiactive case finding sessions
have been planned in the next three years’ national strategic
plan, mainly with the new GFATM grant. All these new
activities are expected to increase TB case finding as follows:
5093 cases by 2016, 5449 by 2017, 5613 by 2018, and 5781 by
2019.
Third, because of the strong relationship between TB
and poverty, TB reduction/elimination undoubtedly will not
be achieved without real improvements in population life
conditions. Although the GDP per capital in Benin grew
from US$ 339 in 2000 to US$ 810 in 2014, the country
remains one of the poorest in the world, with a poverty
headcount ratio of 36% in the general population [18, 19].
A significant improvement in population life conditions is
probably needed to effectively reverse the TB trend in the
country and to achieve the 2035 TB goal of ending TB
epidemic.
The high predominance of NPBCT positive cases on
microscopy with no apparent decrease over the 15 years
confirms the laboratory network efficacy but also raises
the question about early diagnosis of TB in the country.
A positive result on smear microscopy requires an average
concentration of 10000 bacilli per millilitre in sputum spec-
imens [20]. There is a need to advocate for earlier screening
and diagnosis through more education, communication, and
effective screening of close contacts of smear-positive TB
patients [17]. The progressive reduction in the proportion of
retreatment TB patients is, however, a favourable observation
and is likely to be due to improvements in treatment out-
comes of new cases.
We are not surprised that the Atlantique-Littoral region
which houses the economic capital and is burdened with
rural migrations and promiscuity issues remains the one
most affected by the disease; but reasons why the trend of
TB notifications is declining in Borgou should be sought
and addressed. In the same way, reasons for the apparent
seasonality in notified TB cases in the country are not clear.
One suggested hypothesis is the variation in health facilities
utilization in relation to seasons. Access to health facilities in
the rainy season is a problem in many countries, and it might
be expected that a decrease in TB case notifications occurs at
this time. However, this hypothesis is not supported by our
data, since in contrast a higher number of notified TB cases
was often reported during the first semesterwhich iswhen the
main rainy season occurs. There may be other determinants
contributing to TB case finding and notification seasonality
in the country. Seasonality in TB cases finding has also been
reported from elsewhere [21–23]. One hypothesis found in
the literature which attempted to explain such seasonality has
been a variation in Vitamin D, important substance in host
defence, which is produced by the body in association with
sunshine exposure; it may be a factor [24].
With respect to HIV infection, the proportion of patients
with HIV infection has not increased. HIV is an important
driver of the TB epidemic inmany countries. Benin is amixed
epidemic country. Between 2000 and 2013, there has been a
decrease of HIV prevalence in the population aged between
15 and 49 years from 2% to 1.1%. Furthermore, the coverage
rate of ART intake that started in 2002 has progressively
improved. The proportion of HIV-infected patients on ART
increased from 12080 in 2008 to 28850 in 2014 [6, 25]. All of
these factors have probably helped in preventing an increase
in HIV-associated TB in Benin during the last 15 years.
5. Conclusion
The number of TB cases over the last 15 years in Benin has
decreased amongmales and young adults, and the number of
forecasted TB cases predicted to be diagnosed in the next five
years will also decrease if only a passive screening strategy is
continued. Benin needs to decide whether it needs alternative
case finding strategies to meet the End TB Targets by 2035.
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